ASSOCIATION OF BASELINE IL-23 PATHWAY-ASSOCIATED GENE EXPRESSION WITH RISANKIZUMAB-INDUCED CLINICAL REMISSION AND ENDOSCOPIC RESPONSE AT WEEK 12 IN CROHN’S DISEASE PATIENTS
James O. Lindsay 1
Valerie Pivorunas 2
Naim Al Mahi 2
Nizar Smaoui 2
F. Stephen Laroux 2
Bram Verstockt 3
Kristina Kligys 3
Kori Wallace 3
Heath M. Guay 3
Jean-Frédéric Colombel 4
1 Queen Mary University of London, London, United Kingdom
2 AbbVie, Inc, North Chicago, United States
3 University Hospitals Leuven and KU Leuven, Translational Research in Gastrointestinal Disorders - IB, Leuven, Belgium
4 Icahn School of Medicine at Mount Sinai, USA, United States
Topic
Endoscopy, IBD
Session
IL-23-Blockers in IBD: Part 1
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]